MiR-34a acts as a tumor suppressor in various malignancies. In HNSCC, the role of miR-34a in proliferation has not been fully elaborated and the target genes are still bind. Here, we addressed that forced miR-34a expression induced cell cycle arrest and senescence. Hypoxia/HIF1α was found to negatively correlate to the expression of miR-34a in HNSCC tissues and partially reverse miR-34a-imposed cell senescence through suppressing miR-34a expression. In order to screen the possible target genes of miR-34a in HNSCC, the differential genes mediated by miR-34a were screened by mRNA microarray. There were 91 genes co-down regulated in two cell lines, which were closely associated with MAPK, ErbB and p53 pathways. Genes, including FUT1, AXL, and MAP2K1 were finally identified as the novel targets of miR-34a by qPCR and luciferase assay. These findings indicate that miR-34a plays an essential role in suppressing HNSCC growth through inducing cell cycle arrest and senescence, by targeting proliferation-associated genes.
Head and neck squamous cell carcinoma (HNSCC) is an aggressive epithelial neoplasm, which accounts for upwards of 90 percent of head and neck malignancies [1] . The initiation and progression of HNSCC is a multi-step and long-term process which is attributed to accumulation of genetic and epigenetic alterations [2] . In the last few decades, researchers have found that in HNSCC, miRNAs worked as biomarkers for diagnosis and prognosis, and mediate complex biological processes by interactions with various oncogenes or anti-tumor genes [3] .
MicroRNAs, a class of small non-coding RNAs, are 22-24 nucleotides in length. It degrades or silences genes expression post-transcriptionally by fully or partially base-pairing to the complementary sequences in the 3'UTR region of target mRNA. MiR-34a, the most popular member of miR-34 family, has become a novelty tumor-suppressor in diverse malignancies [4] . It is reported to participate in multiple anti-tumor biological processes, such as induction of cell-cycle arrest, senescence, and apoptosis, and reduction of metastasis, angiogenesis and chemo-resistance through regulating different targets [5] [6] [7] [8] [9] [10] [11] . Notably, miR-34a is identified as an essential tumor growth suppressor, because it is a significant downstream target of p53 after DNA damage. P53 activation directly up-regulates miR-34 leading to the induction of the apoptosis, cell cycle arrest, or senescence. Further researches indicate a group of genes, such as SIRT1, Bcl-2, CDK4, cyclin D1 and c-myc, have been identified as direct targets of miR-34a in some solid tumors [12, 13] . Moreover, pathways like Wnt, Notch or Akt signaling, are ascertained to be involved in miR34a mediated cell growth suppressing [14, 15] . It indicates that multiple target genes and molecular signaling are mediated by miR-34a and may vary in different cancer types [16, 17] , because of different pathological and cellular environment.
In HNSCC, the reduction of miR-34a was detected in cell lines and tissues which was associated with cell proliferation, angiogenesis and metastasis [6, 18] . The underlying mechanism of miR-34a in suppressing HNSCC development remains not fully clarified, for few target genes and signaling pathways modulated by miR-34a in HNSCC have been identified. As a result, investigating the changes of cell cycle and cell senescence mediated by miR-34a, and exploring the potential Jiangsu, China) according to the manufacturer's protocol. In brief, cells were plated in 96-well plates at a density of 8×10 2 cells per well and incubated in DMEM supplemented with 10% FBS. At day 1, 2, 4, 6 and 8, cells were treated with 10ul MTT solution per well in the medium, respectively and incubated for 4h. After that, cells were treated with 100ul formazan and incubated until the formazan was dissolved. The absorbance of each well at 570 nm was detected by a microplate reader. Experiments were repeated ≥3 times and data were presented as the mean ± SD.
Flow cytometry assay. 4×10 5 cells per well were seeded into 6-well plates. When the confluence reached 60%, cells were synchronized by serum starvation for 24 h, and re-entered into the cell cycle by an exchange of a medium with 10% FBS DMEM for 24 h. Then cells were harvested by trypsinization and fixed with 75% ethanol at 4 °C overnight. After washing with cold PBS, cells were incubated with RNase A at 37 °C for 30 min and then stained with propidium iodide (PI). The cell cycle status was measured by flow cytometry. The data were analyzed by ModFit software.
SA-β-Gal Staining. β-Gal staining was performed by using a Senescence β-Galactosidase Staining Kit (Beyotime Biotechnology, Jiangsu, China) according to the manufacturer's protocol. 1.5×10 5 cells were incubated in 6-well plates with round cover slips in DMEM supplemented with 10% FBS. After incubation for certain time, cells were fixed with fixing solution for 15 min at RT and washed with phosphate-buffered saline. Then, cells were immersed with SA-β-Gal solution at 37 °C in a CO 2 -free atmosphere until SA-β-gal staining became visible. The cells were stained with Eosin and covered with round coverslips. Through a microscope, the flattened and blue-staining cells were scored as senescent. The senescent rate was calculated as the percentage of the senescent cells on all cells observed per high-power field. Each group cells were counted from 10 random microscopic fields and calculated the mean values.
MRNA microarray analysis. Total RNA was extracted from UM-SCC-23 and Fadu cell lines transfected with premiR-34a or pre-miR-control using Trizol (Invitrogen, Carlsad, CA) according to the manufacturer's protocol and purified by NucleoSpin® RNA clean-up kit (MACHEREY-NAGEL, Germany). The 22k human Genome Array Gene chips using two-channel technology were constructed at Capital BioCorporation. In brief, 5 μg of total RNA was used to synthesize double-stranded cDNA templates and cRNA was obtained using T7 Enzyme Mix. The products of reverse transcription of cRNA were KLENOW enzyme-labeled and then coupled to the Cy5-dCTP or Cy3-dCTP fluorescent dye (GE Healthcare, United States). The labeled-cDNA microarray was dissolved into the hybridization solution and incubated at 42 °C overnight. After washing with 0.2% SDS, 2×SSC buffer, it could be scanned with a confocal LuxScan scanner.
Bioinformatics analysis. Targetscan (http://www.targetscan.org/) and miRbase (http://www.mirbase.org/) were used for predicting the target genes of miR-34a. Pathway analysis 545 MIR-34A MODULATES HNSCC CELL CYCLE ARREST AND SENESCENCE was performed based on the KEGG database (http://www. genome.jp/kegg/). With a P-value <0.05, the enriched pathways were determined.
Cloning of 3'UTR. The full or partial length of 3'UTRs in the candidate genes carrying the putative miR-34a binding sites were amplified by PCR using cDNA from UM-SCC-23 cell line. The 3'UTRs were cloned into the pSiCheck™-2 vector (Promega, Madison, WI, USA) and then verified by sequencing. Point mutations of seed matching sequences were performed with the Quick Change Mutagenesis kit (Stratagene, United States). Oligonucleotides used for cloning and mutagenesis were provided in supplementary data 2 and 3.
Luciferase assays. Fadu cells were seeded in 6-well plat at the density of 5.0 × 10 4 and co-transfected with 40ng the pSiCheck™-2 luciferase vector (carrying wild-type or mutated 3'UTR sequences), 2ug miR-34a or miR-control, using Lipofectamine 2000 (Invitrogen, Carlsad, CA). After 48h, the cells were treated with lysis buffer and the reporter activities were detected in three replicates with the Dual Luciferase Reporter assay system (Promega, Madison, Wisconsin, USA) according to manufacturer's method.
Statistical analysis. All statistical analyses were performed using GraphPad Prism5 software system. All data were presented as the mean ± SEM; groups were compared using two tailed Student's t-test. P values < 0.05 were considered statistically significant.
Results
MiR-34a suppresses proliferation and induces cell cycle arrest in HNSCC cell lines. To verify whether miR-34a was important in suppressing tumor growth, miR-34a was stably over-expressed in Fadu (280.5-fold increase) and UM-SCC-23 (258.2-fold increase) cells by transfecting with pre-miR-34a recombinant lentiviral vector ( Figure 1A ). The cell proliferation rate was assessed by MTT assay at 1-, 2-, 4-, 6-, and 8 day. The result showed that the aberrant expression of miR-34a led to cell growth reduction in the two HNSCC cell lines ( Figure  1B , p<0.05).
To further ascertain miR-34a-mediated proliferation suppression, cell-cycle distribution was detected using flow cytometry assay. Compared with the wide type and control cells, the miR-34a over-expression cells exhibited an about 1.6 to 2.0 times increase in the percentage of cell at G0/G1 phase, along with a decreased cell percentage at the S phase ( Figure 1C ). The result showed that forced miR-34a expression in UM-SCC-23 and Fadu cell lines induced cell cycle arrest at G0/G1 phase.
MiR-34a induces cellular senescence. In order to observe whether the introduction of miR-34a into HNSCC cells induces senescence, the percentage of positive SA-β-Galexpressing cells were calculated. The result showed that the mean percentage of SA-β-gal-positive cells increased by 4.41 times (UM-SCC-23-miR-34a) and 8.18 times (Fadu-miR-34a) in miR-34a over-expression cell lines than that in control cell lines ( Figure 1D , p< 0.0001, Supplementary data 4).
Hypoxia partially reduces miR-34a-imposed cell senescence through suppressing miR-34a in HNSCC cell line. To explore the effect of hypoxia on miR-34a induced cell senescence, the UM-SCC-23 cells with or without miR-34a overexpression were exposed to hypoxia condition at different time point. Under the hypoxia condition, the mean percentage of senescent cells in UM-SCC-23-miR-34a cells was declined with the prolonging of exposure time (Figure 2A, p<0.001) . Although, compared with control cells, miR-34a over-expression cells remained much higher cell senescence rate at the same hypoxic time point (Figure 2A and Supplementary data 5).
To identify whether hypoxia suppresses miR-34a expression, the relative level of miR-34a in UM-SCC-23 cells was investigated. It showed that the miR-34a expression was downregulated under hypoxic environment in a time-dependent manner. (Figure 2B , p< 0.05).
The expression of miR-34a is markedly decreased in the HNSCC tissues with increased HIF1-α level. To detect the relationship between tumor hypoxia micro-environment and miR-34a levels in tissue, the expressions of miR-34a and HIF1-α in HNSCC specimen and adjacent normal epithelial tissues were analyzed by using quantitative RT-PCR. Compared with the adjacent normal epithelial, 15 of 39 HNSCC samples showed increased HIF1-α expression (log2 foldchange≥0.4), 5 samples revealed a reduction of HIF1-α (log2 fold-change ≤ -0.4) and 19 samples showed no significant difference (-0.4<log2 fold-change<0.4) ( Figure 3A) . About 2-fold reduction of miR-34a expression was found in 12 of 15 (80%) HIF1-α elevated samples ( Figure 3B) . Although, the reversed expression trend between miR-34a and HIF1-α was displayed in all 39 tumor tissues, the statistical negative correlation was not significant ( Figure 3C , r 2 =0.0335, p=0.2648). Profile the miR-34a downstream genes by microarray and bioinformatics analysis. To screen the possible downstream genes regulated by miR-34a at mRNA levels in HNSCC cells, the genome-wide mRNA expression of HNSCC cells with or without miR-34a over-expression were performed by two-channel mRNA microarray analysis. Compared with the control, 1578 genes and 1900 genes were detected down-regulated respectively in Fadu-miR-34a and UM-SCC-23-miR-34a cells, when the differential mRNAs with a log2 (fold-change)< -0.6 were considered. To get the intersection, there were 91 genes co-down-regulated in Fadu and UM-SCC-23 on account of miR-34a over-expression. The heat map of the co-down-regulated genes was generated from the microarray data reflecting the expression values ( Figure 4A ).
The pathway analysis based on the KEGG pathway database was manipulated on the 91 co-down-regulated genes. The KEGG enrichment analysis revealed that these genes were strikingly involved in MAPK signaling pathway, ErbB signaling pathway and p53 pathway, and moderately regulated the biological process of apoptosis, methionine metabolism, T cell receptor signaling pathway and so on ( Figure 4B ). 
MAP2K1, AXL, FUT1 and AREG are the direct targets of miR-34a in HNSCC.
Using in-silico miRNA targets identification tools, miRbase and Targetscan4.2, twenty-five of the ninety-one genes were identified as potential targets of miR-34a ( Figure 5A ). Considering the mRNA fold-change, mRNA abundance (the fluorescence intensity ≥1000) and gene function associated with tumorigenesis, 11 of the 25 genes were selected to be further analyzed, which were revealed in Figure 5A .
To verify whether those 11 genes were down regulated by miR-34a in HNSCC cells, the mRNA expression level was detected by qRT-PCR. The result indicated that the mRNA levels of 8 genes were reduced about 1.4-fold to 4.7-fold in cells with ectopic miR-34a expression, compared with control ( Figure 5B ).
To further confirm whether the 8 candidate genes were directly targeted by miR-34a, dual reporter assay was performed, respectively. AREG was validated to be a direct target gene involving in metastasis in our previous study [6] . The luciferase reporter pSiCheck™-2 carrying wide-type or mutant 3'UTR sequences of the other 7 genes were constructed and then co-transfected with either miR-34a or miR-control in Fadu cell line ( Figure 6A ). The luciferase reporter activity of pSiCheck™-2-AXL-3'UTR, pSiCheck™-2-FUT1-3'UTR and pSiCheck™-2-MAP2K1-3'UTR was markedly reduced by forced expression of miR-34a compared with the control (2.43-fold decrease, 2.08-fold decrease and 4.78-fold decrease, respectively), whereas no reporter activity were found when their target sites were mutated ( Figure 6B-C) . According to Targetscan, the 3'UTR of FUT1 mRNA has two predicted binding sites of miR-34a. To identify the two binding sites respectively, reporter vector pSiCheck™-2 carrying point mutations at the two putative seed binding sequences were respectively constructed. The result demonstrated that when mutagenesis at the position 1567-1574 of FUT1 3' UTR (mut1), miR-34a had a minimal effect on reporter activity; while when mutagenesis at the position 1641-1647 (mut2), the significant reduction of reporter activity was still detected. The result indicated that position 1567-1574 of FUT1 3' UTR (mut1) is the specific target sequence of miR-34a.
In addition, in order to investigate the effect of hypoxia on miR-34a target genes, the mRNA expressions of FUT1, AXL, AREG and MAP2K1 were evaluated after hypoxia for 24 hours. The result showed that the relative mRNA expression levels of MAPK2 and FUT1 in HNSCC cell lines were significantly induced, when miR-34a was suppressed by hypoxia, while AREG and AXL remained unchanged (Supplementary data 6).
Discussion
Head and neck cancer represent an intramurally heterogeneous cohort of malignant tumors which originate from oral cavity, oropharynx, hypopharynx, or larynx [6] . This disease can significantly interfere with psychological health and life quality of the patients [19, 20] . Investigations of potential biomarkers and therapeutic targets have become focal point in the molecular oncology of HNSCC. Numerous evidences have indicated that miRNAs, involved in the initiation and progression of tumors, possess an anti-tumor activity in HNSCC.
MiR-34a is one of the best-studied miRNAs associated with malignancies. It is located at the chromosome lp36 locus, where is susceptive of chromosomal aberration and induces multiple molecular events thereby disturbing the dynamic cell balance of proliferation, apoptosis, senescence and metastasis [21] [22] [23] [24] [25] . In HNSCC, the decreased expression of miR-34a was observed previously [6] . The present study further demonstrated that ectopic miR-34a expression retarded proliferation and induced G0/G1 cell cycle arrest in HNSCC cell lines, which was consistent with observations in colon cancer, hepatocellular cancer and non-small cell lung cancer [26] [27] [28] . On the other hand, miR-34a was reported to promote cell senescence in vascular smooth muscle cells, colon cancer and hepatocellular cancer [29] [30] [31] . Here, we provided evidence that miR-34 promoted cell senescence in HNSCC. Although the direct target of miR-34a involved in senescence was still ambiguous in HNSCC, based on our bioinformatics data, several genes and signaling pathways involved in senescence or cell death were significantly downregulated, such as MAPK and P53 signaling pathway, TFE3, and MEK1. Additionally, we observed that hypoxia could suppress miR-34a expression, thereby reducing miR-34a imposed cell senescence. It was suggested that miR-34a, acted as an inhibitor of tumor cell growth through cell cycle arrest and cellular senescence, could constitute a bona fide barrier to progression of HNSCC, whereas intro-tumor hypoxia could impair the binding effect of miR-34a on tumor growth through decreasing its expression. Moreover, the relative mRNA expression levels of MAPK2 and FUT1 in HNSCC cell lines were detected significantly induced by hypoxia, while AREG and AXL remained unchanged. The result might indicate that MAPK2 and FUT1, the potential target genes suppressed by miR-34a, were induced by hypoxia, which might be because that miR-34a was significantly reduces under the hypoxic environment.
To ascertain target genes of miR-34a is of major significance to decipher its molecular functional mechanism in tumor development. Our research identified FUT1, AXL, and MAP2K1 as the direct targets of miR-34a. FUT1, which encodes α1, 2-fucosyltransferase and transfers a fucose residue to galactose, is of key significance to the biosynthesis of Lewis Y antigen [32] . Up-regulated Lewis Y has been found in various tumors including breast, ovarian, and colorectal cancer [33] [34] [35] , leading to tumor growth acceleration and lymph node metastasis through activating ErbB signaling [36] . To our knowledge, FUT1 is for the first time to be demonstrated as the target of miR-34a. The specificity target sequence of FUT1 3'UTR is at the 1567-1574 region, but not the 1641-1647 region. Coincidentally, AREG, another target confirmed in HNSCC, is also tightly associated with ErbB signaling. By binding to the EGFR, AXL, a member of receptor tyrosine kinases [37] , stimulates a mix of physiological processes of normal cells or cancer cells [38] [39] . Studies indicate that the capacity of HNSCC cellular growth, migration, and invasion are dependent on AXL through PI3K/AKT and MAPK signaling [40, 41] . It is well-known miR-34a targets AXL in non-small lung cancer, ovarian cancer, B-cell chronic lymphocytic, breast cancer and colorectal cancer resulting in tumor proliferation [42] [43] [44] . In HNSCC, the direct interaction between miR-34a and AXL was evidenced in this study, demonstrating AXL might be a common target of miR-34a in malignant tumors. As the central node in the MAPK signaling cascade (Ras/ 551 MIR-34A MODULATES HNSCC CELL CYCLE ARREST AND SENESCENCE Raf/Mek/ERK), MAP2K1 is another newly detected target of miR-34a in HNSCC. It is a dual-specificity tyrosine threonine protein kinase and confers hallmarks of cancer cells such as cell growth, migration and invasion via phosphorylation of ERK1 and ERK2. It has been reported miR-34a targeted MAP2K1 hampering cell proliferation during megakaryocytic differentiation of K562 cells [45] . Thus, it shows that miR-34a may suppress HNSCC proliferation through mainly inhibiting the MAPK and ErbB signaling pathway. In addition, we found that the relative mRNA expression levels of MAPK2 and FUT1 were significantly induced, when miR-34a was suppressed by hypoxia. The result indicates that miR-34a might play an important role in hypoxia induced MAPK2 and FUT1. They induced by hypoxia might be because that miR-34a was significantly reduced under the hypoxic environment.
Gene expression profiling has emerged as an effective approach to study the mechanism of miR-34a in HNSCC development from comprehensive perspective. Among the downstream genes, even though most of them do not carry putative miR-34a binding sites in their 3'UTRs, it was likely to be a secondary consequence of the targets of miR-34a. Furthermore, the bioinformatics analysis showed that these downstream genes consisted of signaling nodes, enzymes and transcription factors, which were enriched in the MAPK, ErbB and P53 signaling pathways. MiR-34a may involve in multiple tumor suppressive pathways by directly or indirectly inhibiting the expression of numerous oncogenes and acts as a molecular switch in a complicated regulatory network.
In HNSCC, besides the inhibition of metastasis with a pivotal target AREG previously reported by our research group, the anti-growth effect of miR-34a via cell cycle arrest and senescence was investigated in the present study. Then 3 novel target genes (FUT1, AXL, and MAP2K1) of miR-34a involved in ErbB and MAPK signaling pathways were identified through mRNA array and luciferase array. It is well known miRNAs post-transcriptionally regulate gene expression by not only mRNA degradation but translational silencing. Future studies combining high-throughput mRNA with proteomics sequencing would further clarify the mechanisms of miR-34a in HNSCC cell proliferation.
